Jane Street’s Virtus Biotech ETF BBP Stock Holding History
Bought
Maintained
Sold
Other funds holding BBP
CAMG
WI
Jane Street's BBP Position: Q2 2026 in Review
Jane Street sold out of Virtus Biotech ETF (BBP) in Q2 2026, closing a stake of 10,883 shares — an estimated $904K sold.
Jane Street first reported a position in BBP in Q2 2015 and held it in 18 quarters. The position peaked at $2.16M in Q3 2025. 25 funds tracked by Wall St. Rank hold BBP as of Q2 2026.
- Jane Street reported no remaining Virtus Biotech ETF position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 10,883 Virtus Biotech ETF shares in Q2 2026, an estimated $904K.
- Jane Street first reported a position in Virtus Biotech ETF in Q2 2015 and held it in 18 quarters.
- Jane Street's Virtus Biotech ETF position peaked at $2.16M in Q3 2025.
- 25 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.